Media Summary: This presentation discussed FDA's perspective on Learn the essential principles behind rigorous The first of two Q&A discussion panels for day three of the

Citc 2024 D3s01 Achieving Fit For Purpose Clinical Trial Quality - Detailed Analysis & Overview

This presentation discussed FDA's perspective on Learn the essential principles behind rigorous The first of two Q&A discussion panels for day three of the This presentation provided a comprehensive overview of FDA's Bioresearch Monitoring (BIMO) Program and discussed the Good ... Discover the critical safety principles that guide the earliest stages of human drug This annual training course provided participants with the essential knowledge and skills to conduct

This presentation described significant changes in the Explore the critical importance of including diverse populations in The first of three Q&A discussion panels for day two of the This presentation highlighted the significance of international This presentation explored how electronic technologies are revolutionizing

Photo Gallery

CITC 2024 – D3S01 – Achieving Fit-for-Purpose Clinical Trial Quality
CITC 2024 – D1S02 – Basics of Clinical Trial Design
FDA Clinical Investigator Training Course (CITC) 2024 (Day 1 of 3)
CITC 2024 – D3S04 – Q&A Discussion Panel 1
CITC 2024 – D3S05 – FDA’s Good Clinical Practice Compliance Review for NDAs and BLAs
CITC 2024 – D1S05 – Safety Considerations in Clinical Drug Development
CITC 2024 – D2S03 – Clinical Pharmacology: Early Drug Development
CITC 2024: FDA Investigator Training Day 1, Session 2 (Condensed)
FDA Clinical Investigator Training Course (CITC) 2024 – Day Two – Session One
FDA Clinical Investigator Training Course (CITC) 2024 – Day One – Session One
CITC 2024 – D3S07 – FDA’s Use of Alternative Approaches to Evaluate GCP Compliance
CITC 2024 – D1S06 – Specific Populations in Clinical Trials
Sponsored
Sponsored
View Detailed Profile
CITC 2024 – D3S01 – Achieving Fit-for-Purpose Clinical Trial Quality

CITC 2024 – D3S01 – Achieving Fit-for-Purpose Clinical Trial Quality

This presentation discussed FDA's perspective on

CITC 2024 – D1S02 – Basics of Clinical Trial Design

CITC 2024 – D1S02 – Basics of Clinical Trial Design

Learn the essential principles behind rigorous

Sponsored
FDA Clinical Investigator Training Course (CITC) 2024 (Day 1 of 3)

FDA Clinical Investigator Training Course (CITC) 2024 (Day 1 of 3)

This course aims to prepare

CITC 2024 – D3S04 – Q&A Discussion Panel 1

CITC 2024 – D3S04 – Q&A Discussion Panel 1

The first of two Q&A discussion panels for day three of the

CITC 2024 – D3S05 – FDA’s Good Clinical Practice Compliance Review for NDAs and BLAs

CITC 2024 – D3S05 – FDA’s Good Clinical Practice Compliance Review for NDAs and BLAs

This presentation provided a comprehensive overview of FDA's Bioresearch Monitoring (BIMO) Program and discussed the Good ...

Sponsored
CITC 2024 – D1S05 – Safety Considerations in Clinical Drug Development

CITC 2024 – D1S05 – Safety Considerations in Clinical Drug Development

Discover the critical safety principles that guide the earliest stages of human drug

CITC 2024 – D2S03 – Clinical Pharmacology: Early Drug Development

CITC 2024 – D2S03 – Clinical Pharmacology: Early Drug Development

This presentation defined

CITC 2024: FDA Investigator Training Day 1, Session 2 (Condensed)

CITC 2024: FDA Investigator Training Day 1, Session 2 (Condensed)

The video titled "FDA

FDA Clinical Investigator Training Course (CITC) 2024 – Day Two – Session One

FDA Clinical Investigator Training Course (CITC) 2024 – Day Two – Session One

This annual training course provided participants with the essential knowledge and skills to conduct

FDA Clinical Investigator Training Course (CITC) 2024 – Day One – Session One

FDA Clinical Investigator Training Course (CITC) 2024 – Day One – Session One

This annual training course provided participants with the essential knowledge and skills to conduct

CITC 2024 – D3S07 – FDA’s Use of Alternative Approaches to Evaluate GCP Compliance

CITC 2024 – D3S07 – FDA’s Use of Alternative Approaches to Evaluate GCP Compliance

This presentation described significant changes in the

CITC 2024 – D1S06 – Specific Populations in Clinical Trials

CITC 2024 – D1S06 – Specific Populations in Clinical Trials

Explore the critical importance of including diverse populations in

CITC 2024 – D2S04 – Q&A Discussion Panel 1

CITC 2024 – D2S04 – Q&A Discussion Panel 1

The first of three Q&A discussion panels for day two of the

CITC 2024 – D3S06 – Clinical Investigator Inspection Readiness

CITC 2024 – D3S06 – Clinical Investigator Inspection Readiness

This presentation described the

FDA Clinical Investigator Training Course (CITC) 2024 (Day 3 of 3)

FDA Clinical Investigator Training Course (CITC) 2024 (Day 3 of 3)

This course aims to prepare

SWOG Spring 2023 Hybrid Group Meeting: CRA Clinical Trials Training Course

SWOG Spring 2023 Hybrid Group Meeting: CRA Clinical Trials Training Course

Recording of the CRA

Clinical Trials Training Course (CTTC): Session #2

Clinical Trials Training Course (CTTC): Session #2

Recording of the

CITC 2024 – D3S03 – International Clinical Trials

CITC 2024 – D3S03 – International Clinical Trials

This presentation highlighted the significance of international

CITC 2024 – D2S05 – Innovative Approaches to Clinical Trials

CITC 2024 – D2S05 – Innovative Approaches to Clinical Trials

This presentation explored how electronic technologies are revolutionizing